title: Velopharyngeal Incoordination Caused by Phenytoin-Induced Toxicity.
abstract: Phenytoin induces lymphoid proliferation, resulting in complications that can range from tissue hyperplasia to lymphoma. Some of the complications resolve spontaneously after drug discontinuation. This report describes for the first time a case of dysphagia with lack of velopharyngeal coordination and nasopharyngeal reflux combined with massive palatine tonsillar hypertrophy. The condition did not develop before phenytoin administration, was induced by phenytoin, and spontaneously resolved upon drug discontinuation. The patient was referred for a video-fluoroscopic swallowing study owing to a recurring nasal reflux of foods that had developed since phenytoin administration. The video-fluoroscopic swallowing study revealed incidentally that the large bilateral elongated masses extended downward into the larynx and disturbed velar elevation. This finding was confirmed by computed tomography of the neck, which showed that palatine tonsillar hypertrophy disturbed the laryngopharynx on both sides. The symptoms (sleep apnea and nasal reflux) and the abnormal imaging findings disappeared without surgery approximately 1 month after drug discontinuation. This case suggests that dysphagia related to phenytoin-induced lymphoid hypertrophy may be treated by phenytoin discontinuation followed by a sufficient amount of time to allow symptom resolution rather than by prompt surgery.
authors.affiliation: From the Department of Physical Medicine and Rehabilitation, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
authors.forename: Chang Ho
authors.initials: CH
authors.lastname: Hwang
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D001259:Ataxia / Q000139:chemically induced*; D003680:Deglutition Disorders / Q000139:chemically induced*; D005764:Gastroesophageal Reflux / Q000209:etiology*; D006801:Humans; D006984:Hypertrophy / Q000139:chemically induced; D008297:Male; D014066:Palatine Tonsil / Q000473:pathology; D010609:Pharyngeal Muscles / Q000503:physiopathology*; D010672:Phenytoin / Q000009:adverse effects*; D012640:Seizures / Q000188:drug therapy
chemical_list: D000927:Anticonvulsants; D010672:Phenytoin